Medicare Extends Part B Coverage for Kidney Transplant Drugs

Patients with Medicare because of End-Stage Renal Disease (ESRD) currently lose coverage 36 months after a kidney transplant unless otherwise eligible for Medicare. A recently published final rule will extend coverage for patients who meet certain criteria to qualify for continuous Medicare-covered immunosuppressive drugs starting January 1, 2023. This new benefit is called Medicare Part B Immunosuppressive Drug (Part B-ID).

There are a few important limitations to be aware of including:

Become an audit assistance member today to continue reading this article. As a member, you’ll have access to hundreds of articles and receive our monthly proactive newsletter!

  1. It only covers immunosuppressive drugs and no other items or services
  2. Patients who have other health coverage are not eligible to enroll
  3. Patients must provide notice to Social Security Administration within 60 days if they sign up for other coverage
  4. Patients will be responsible for annual Part B deductible and 20% coinsurance

PAAS Tips:

Eric Hartkopf, PharmD